UGX202 Injection in Patients With Advanced Retinitis Pigmentosa

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
UGX202 Injection in Patients With Advanced Retinitis Pigmentosa	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa	Not yet recruiting	Early phase 1	2025-12-31		NCT07311863

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eye & ENT Hospital of Fudan University	64
Suzhou UgeneX Therapeutics Co., Ltd.	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Eye & ENT Hospital of Fudan University	Shanghai	China	17

Clinical trials